Local Institution - 008 — New York, New York

Local Institution - 008 is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Local Institution - 008 has participated in 2 clinical trials.

Therapeutic areas: Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL).

Sponsors: Juno Therapeutics, a Subsidiary of Celgene, Celgene.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 008?

Local Institution - 008 has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 008 conducted?

Local Institution - 008 has 2 clinical trials on record. Their work covers Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL).

Is Local Institution - 008 accredited by Crixeo Health?

Local Institution - 008 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 008?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.